APOLLOHOSP gained +1.1% on at day's high
Apollo Hospitals Enterprise Ltd. closed the session at ₹8,508.5, up 1.15 per cent from its previous close of ₹8,411.5, even as the broader Nifty 50 slipped 0.64 per cent. The stock opened with a modest gap-up of 0.21 per cent and steadily climbed through the day to touch an intraday high of ₹8,510, just ₹1.5 shy of its closing price. The day's low of ₹8,420 came early in the session, after which the stock held firm in positive territory and finished near its peak.
The technical picture shows a stock trading in firm uptrend territory. The 14-day relative strength index stands at 63.6, below overbought levels but indicating sustained buying pressure. Apollo Hospitals is currently 1.56 per cent below its 52-week high and has gained 26.78 per cent from its 52-week low. It trades above both its 50-day and 200-day simple moving averages, a configuration that typically signals medium- and long-term strength. However, volume participation was relatively subdued — relative volume came in at 0.82, meaning today's turnover ran about 18 per cent below the 20-day average. The stock has returned 2.18 per cent over the past month, though the past week saw a marginal decline of 0.10 per cent.
The derivatives footprint is blank today — no futures or options positioning data was captured in the session, so there is no read on whether traders were building fresh longs, covering shorts, or rolling positions. Institutional deal flow over the past 30 days shows no block trades or bulk deals recorded, and there is no streak of consecutive buying or selling sessions from large funds. Insider filings over the past 60 days are similarly empty, with no reported purchases or disposals by promoters or key management personnel.
On the news front, the most recent headline touching Apollo Hospitals directly came five days ago from scanx.trade, which reported that the company had outlined governance arrangements and an upside agreement for Apollo HealthTech. Beyond that, the news flow thins out. A 12-day-old Business Today headline included Apollo Hospitals in a list of top stocks to watch, and a 30-day-old TradingView piece noted the shares had hit a 52-week high on strong Q4 results. The GuruFocus.com headline from 28 days ago referenced a Q4 2026 earnings call with record revenue, though this appears to be a forward-dated or erroneous reference given the calendar. None of these items directly explain today's move.
The data shows no single obvious catalyst for the 1.15 per cent advance. What is visible is a stock continuing to hold its structure near lifetime highs, attracting selective buying on a day when the broader market weakened. The watch zone for Friday's session sits at ₹8,510 on the upside — a sustained close above that level would signal continuation, while a drop back below ₹8,411.5 would flip the short-term bias bearish. With earnings not immediately due and no fresh institutional or insider activity to parse, traders are left reading price action and relative strength for cues.
The numbers
- Last price ₹8,508.50, +1.15% on the day
- Day range ₹8,420.00 – ₹8,510.00
- Opening gap +0.21%
- NIFTY moved -0.64% the same session
Signals that fired
- At day's high
- vs NIFTY -0.64%
Technical context
Volume ran at 0.8× its 20-day average; rsi(14) sits at 64; price is 1.6% from the 52-week high; trading above the 50-dma and 200-dma.
Recent headlines
- Apollo Hospitals outlines Apollo HealthTech governance and upside agreement — scanx.trade (5d ago)
- Personalised gummies firm Rem3dy Health raises funds for global push — Just Food (10d ago)
- Hijos de Rivera invests in gummies firm Rem3dy Health — Just Drinks (10d ago)
- Apollo Hospitals, Federal Bank, GAIL, NBCC: Top stocks to buy - targets, stop loss & more — Business Today (12d ago)
- Apollo Hospitals Q4 FY25 preview: Revenue, margins, and expansion updates expected — Value Research (21d ago)
- From diapers to drugs: How India's global corporate hubs are putting AI to work — Reuters (23d ago)
- Apollo Hospitals Enterprise Ltd (BOM:508869) Q4 2026 Earnings Call Highlights: Record Revenue ... — GuruFocus.com (28d ago)
- Apollo Hospitals shares hit 52-week high on strong Q4 results; should you buy, sell or hold? — TradingView (30d ago)
Sources
- Apollo Hospitals outlines Apollo HealthTech governance and upside agreement — scanx.trade
- Personalised gummies firm Rem3dy Health raises funds for global push — Just Food
- Hijos de Rivera invests in gummies firm Rem3dy Health — Just Drinks
- Apollo Hospitals, Federal Bank, GAIL, NBCC: Top stocks to buy - targets, stop loss & more — Business Today
- Apollo Hospitals Q4 FY25 preview: Revenue, margins, and expansion updates expected — Value Research
- From diapers to drugs: How India's global corporate hubs are putting AI to work — Reuters
- Apollo Hospitals Enterprise Ltd (BOM:508869) Q4 2026 Earnings Call Highlights: Record Revenue ... — GuruFocus.com
- Apollo Hospitals shares hit 52-week high on strong Q4 results; should you buy, sell or hold? — TradingView
Keep digging
- APOLLOHOSP — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.